QuVa Pharma, Inc. recalls
Every recall we track for QuVa Pharma, Inc. — 38 in all, from 2016–2026 — plus the complaints and injury reports the public filed about them. 24 are rated “stop using now”.
Recalls per year, by danger level
Recalls from QuVa Pharma, Inc. peaked in 2019 (27); 37 since 2017. 62% rated “stop using now”.
All FDA recall records for QuVa Pharma, Inc. since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 2 | 0 | 2 |
| 2019 | 21 | 4 | 1 | 1 | 27 |
| 2020 | 1 | 1 | 0 | 0 | 2 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 1 | 1 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 0 | 2 | 1 | 4 |
| 2026 (to date) | 0 | 0 | 0 | 1 | 1 |
QuVa Pharma, Inc. recalls before 2017
Recalls on record by year.
Most common reasons for QuVa Pharma, Inc. recalls
What to do if you have a recalled QuVa Pharma, Inc. product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All QuVa Pharma, Inc. recalls
10 shown- UnratedDrug
QuVa Pharma, Inc. recalls Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Compounded drug, QuVa Pharma, 1075 W Park
QuVa Pharma recalls specific lots of Methohexital Sodium injection due to failed impurity specifications. Check lot numbers and expiration dates for affected units.
QuVa PharmaJun 24, 2026 - Lower riskDrug
QuVa Pharma, Inc. recalls R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl, and Ketorolac Tromethamine) in Sodium Chloride Solution, Total
QuVa Pharma recalls R.E.C.K. (Ropivacaine HCl, Epinephrine, Clonidine HCl, Ketorolac Tromethamine) in Sodium Chloride Solution for periarticular use due to particulate matter. This compounded drug may cause blockages if injected.
QuVa PharmaOct 10, 2025 - Stop using nowDrug
QuVa Pharma, Inc. recalls fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.125% Bupivacaine HCl 125 mg/100 mL (1.25 mg/mL), 100 ml in NS Yellow
QuVa Pharma recalls specific fentanyl injections due to lack of sterility assurance. Affected lots expire April 2025. Consumers should not use these products.
QuVa PharmaMar 6, 2025 - UnratedDrug
QuVa Pharma, Inc. recalls oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride, Injection for IV Use, High Alert, This is a
QuVa Pharma recalls oxyTOCIN 30 Units/500mL IV solution due to incorrect sodium chloride concentration (0.45% instead of 0.9%). This compounded product for institutional use may cause complications if administered improperly.
QuVa PharmaSep 20, 2022 - Stop using nowDrug
QuVa Pharma, Inc. recalls oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride Injection for IV Use, Rx only, QuVa Pharma 1075
QuVa Pharma recalls 648 bags of oxyTOCIN IV injection because the product did not contain the drug, posing a subpotent hazard.
QuVa PharmaMay 28, 2020 - Use cautionDrug
QuVa Pharma, Inc. recalls R.E.C.K. (Ropivacaine, Epinephrine, Clonidine, Ketorolac) in Sodium Chloride solution 50 mL in 60 mL Syringe,
QuVa Pharma recalls R.E.C.K. (Ropivacaine, Epinephrine, Clonidine, Ketorolac) vials with particulate matter risk. Affected lots and expiration dates listed.
QuVaApr 23, 2020 - Stop using nowDrug
QuVa Pharma, Inc. recalls fentaNYL 2000 mcg/100 mL (20 mcg/mL) in 0.9% Sodium Chloride, 100 mL Bag, Preservative Free, Rx, QuVA Pharma 1075 West
QuVa Pharma recalls fentanyl 2000 mcg/100mL bags due to potential glass particles. Affected lots expire through January 2020. Consumers should check product details and contact manufacturer for guidance.
QuVa PharmaNov 12, 2019 - Lower riskDrug
QuVa Pharma, Inc. recalls Norepinephrine 8 mg (32 mcg/mL) added to 0.9% Sodium Chloride Injection 250 mL Bag, Rx only, Compounded by: QuVA Pharma
QuVa Pharma recalls norepinephrine injection compounded with 5% dextrose instead of 0.9% sodium chloride. This may cause incorrect dosing. Contact for details.
QuVa PharmaNov 21, 2018 - Lower riskDrug
QuVa Pharma, Inc. recalls Norepinephrine 4 mg (16 mcg/mL) added to 5% Dextrose 250 mL Bag Preservative Free, Rx only, QuVa Pharma, 519 Route 173,
QuVa Pharma recalls Norepinephrine 4 mg bags due to potential lack of active ingredient. Affected units may not deliver proper medication dose.
QuVa PharmaAug 27, 2018 - Stop using nowDrug
QuVa Pharma, Inc. recalls PHENYLephrine 1 mg/10 mL (100 mcg/mL) in 0.9% Sodium Chloride, 10 mL syringe, packaged in 24 syringes per case, Rx
QuVa Pharma recalls 20 cases of Phenylephrine syringes in CA due to incorrect strength labeling on the overwrap. Check lot numbers.
QuVa PharmaMar 30, 2016
QuVa Pharma, Inc. recall questions
How many recalls has QuVa Pharma, Inc. had?
38 recalls from QuVa Pharma, Inc. are on record with U.S. safety agencies, from 2016–2026.
What is the most recent QuVa Pharma, Inc. recall?
QuVa Pharma, Inc. recalls Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Compounded drug, QuVa Pharma, 1075 W Park, dated Jun 24, 2026. Every QuVa Pharma, Inc. recall is listed on this page, newest first.
Why are QuVa Pharma, Inc. products recalled?
The most common reasons on record: Lack of Assurance of Sterility (3).
What should I do if I have a recalled QuVa Pharma, Inc. product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new QuVa Pharma, Inc. recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.